Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 4, 2003 - Issue 11
Submit an article Journal homepage
66
Views
14
CrossRef citations to date
0
Altmetric
Review

Cost-assessment of alternative management strategies for achalasia

Marcelo F Vela Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA. [email protected]
&
Michael F Vaezi Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA. [email protected]
Pages 2019-2025 | Published online: 02 Mar 2005

Bibliography

  • MAYBERRY JF: Epidemiology and demographics of achalasia. Gasmointest. Endos. Clin. N Am. (2001) 11:235–247.
  • WONG RKH, MAYDONOVITCH CL: Achalasia. In: The Esophagus (..?-d edit), Castell DO, Richter JE (Eds), Lippincott Williams & Wilkins, Philadelphia, USA (1999):185–213.
  • VAEZI MF, RICHTER JE: Diagnosis and management of achalasia. Am. J. Gastroenterol (1999) 94:3406–3412.
  • VELA ME RICHTER JE: Presentation and management of achalasia at a tertiary center - a complicated disease. Gastroenterolgy (2003) 124:A–236.
  • VVEINSTEIN MC, STASON WB:Foundations of cost-effectiveness analysis for health and medical practices.N Engl. I Med. (1977) 296:716–721.
  • PROVENZALE D, LIPS COM J:Cost-effectiveness: definitions and use inthe gastroenterology literature. Am. J.Gastroenterol (1996) 91:1488–1493.
  • PARKMAN H, REYNOLDS J,OUYANG A et al.: Pneumatic dilatation or esophagomyotomy treatment for idiopathic achalasia: clinical outcomes and cost analysis. Dig. Dis. Sci. (1993) 38:75–85.
  • SPECHLER SJ: AGA technical review on treatment of patients with dysphagia caused by benign disorders of the distal esophagus.Gastroenterology (1999) 117:223–254.
  • VAEZI ME RICHTER JE: Current therapies for achalasia: comparison and efficacy.' Clin. Gastroenterol (1998) 27:21–35.
  • •A good review of treatments for achalasia.
  • GELFOND M, ROZEN P, GILAT T:Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation.Gastroenterology (1982) 83:963–969.
  • BORTOLOTTI M, MARI C,LOPILATO C et al: Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology (2000) 118:253–257.
  • BANBURY MK, RICE TW,GOLDBLUM JR et al.: Esophagectomywith gastric reconstruction for achalasia.Thome. Cardiovasc. &lig. (1999) 117:1077–1085.
  • PASRICHA PJ, RAVICH WJ, HENDRIX TR et al.: Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl. J. Med. (1995) 322:774–778.
  • PASRICHA PJ, RUDRA R, RAVICH WJet al.: Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology (1996) 110:1410–1415.
  • VAEZI MJ, RICHTER JE, WILCOX CMet al.: Botulinum toxin versus pneumaticdilation in the treatment of achalasia: a randomized trial. Gut (1999) 44:231–239.
  • •A randomised, controlled trial.
  • ANNESE V, BASCIANI M, PERRI F et al:Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology (1996) 111:1418–1424.
  • MIKAELI J, FAZEL A, MONTAZERI Get al.: Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Aliment. Pharmacol Titer. (2001) 15:1389–1396.
  • WEST RL, HIRSCH DP,BATELSMAN JF et al.: Long term results of pneumatic dilatation in achalasia followed for more than 5 years. Am. J. Gastroenterol (2002) 97:1346–1351.
  • ••A retrospective review of PD withlong-term follow-up.
  • KADAKIA SC, WONG RKH: Pneumatic balloon dilation for esophageal achalasia. Gastrointest. Endosc. Clin. North Am. (2001) 11:325–345.
  • AMJAD A, PELLEGRINI CA: Laparoscopic myotomy: technique and efficacy in treating achalasia. Gastrointest. Endosc. Clin. North Am. (2001) 11:347–357.
  • RICHTER JE: Oesophageal motility disorders. Lancet (2001) 358:823–828.
  • SPIESS AE, KAHRILAS PJ: Treating achalasia: from whalebone to laparoscope. JAMA (1998) 280:638–642.
  • •A good review of the treatments for achalasia.
  • CSENDES A, BRAGHETTO I, HENRIQUEZ A et al.: Late results of a prospective randomized study comparing forceful dilatation and esophagomyotomy in patients with achalasia. Gut (1989) 30:299–304.
  • KJELLIN AP, GRANQUIST S, RAMEL S,THOR KBA: Laparoscopic myotomy without fundoplication in patients with achalasia. Ear: J. Sing. (1999) 165:1162–1166.
  • SWANSTROM LL, PENNINGS J: Laparoscopic esophagomyotomy for achalasia. Slug. Endosc. (1995) 9:286–272.
  • VELA MF, RICHTER JE: Treatment of esophageal motility disorders: achalasia, and spastic motor disorders. In: Evidence Based Gastroenterology and Hepatology (2'd ed.& Burroughs A, Feagan B, McDonald J (Eds), London: Br. Med. I Books, (2003) (In Press).
  • •A good review with an evidence-based approach.
  • DI SIMONE P, FELICE V, D'ERRICO A et al: Onset timing of delayed complications and criteria of follow-up after operation for esophageal achalasia. Ann. Thorne. Surg. (1996) 61:1106–1111.
  • PANACCIONE T, GREGOR JC, REYNOLDS RPE, PREIKSAITIS HG: Intrasphincteric botulinum toxin versus pneumatic dilatation for achalasia: a cost minimization analysis. Gastrointest. Enclose. (1999) 50:492–298.
  • ••A decision model cost-analysis.
  • GHOSHAL UC, AGGARWAL R, KUMAR S, NAIK SR: Pneumatic dilatation versus intrasphincteric botulinum toxin injection in the treatment of achalasia cardia in India: an economic analysis. Indian .1. Gastroenterol (2002) 21:193–196.
  • ZARATE N, MEARIN F, BALD OVINO Fet al.: Achalasia treatment in the elderly: is botulinum toxin injection the best option? Eur. Gastroenterol Hepatol (2002) 14:285–290.
  • ALLESCHER HD, STORR M, SEIGE M et al.: Treatment of achalasia: botulinumtoxin injection versus pneumatic balloon dilation. A prospective study with long-term follow-up. Endoscopy (2001) 31:1007–1017.
  • ANCONA E, ANSELMINO M, ZANINOTTO G et al.: Esophageal achalasia: laparoscopic versus conventional open Heller-Dor operation. Am.' Surg. (1995) 170:265–270.
  • IMPERIALE TF, O'CONNOR JB, VAEZI MF et al.: A cost analysis of alternative treatment strategies for achalasia. Am.j Gastroenterol (2000) 85:2737–2745.
  • ••A cost-minimisation model.
  • O'CONNOR JB, SINGER ME, IMPERIALE TF, VAEZI MERICHTER JE: The cost-effectiveness of treatment strategies for achalasia. Dig. Dis. ScL (2002) 47(7):1516–1525.
  • ••A cost-effectiveness model with quality oflife assessment.

Websites

  • http://www.uptodate.com/index.asp BONIS PAL, WONG JB: A short primer on cost-effectiveness analysis. UpToDate (2003). Acessed August 30, 2003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.